Skip to content

Molecular perspective on the effect of Yoga on Chronic Kidney Disease and Health Related Quality of Life - A Randomized Control Trial

Molecular basis of the effect of Yoga based intervention on Chronic Kidney Disease and Health Related Quality of Life outcomes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009846
Enrollment
90
Registered
2017-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Kidney Disease

Interventions

Intervention1: Yoga Group: Asana, Pranayama, Meditation One hour per day - Five days a week and - for Three months Control Intervention1: Control Group: usual daily routine only

Sponsors

Self funded
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients identified with CKD Stages 3 & 4 [15 Patients identified with nephropathy (Diabetics or Hypertensive nephropathy) Age ranging from 35 to 60 from both gender Willingness to participate in a 12 - week yoga program

Exclusion criteria

Exclusion criteria: Persons identified / diagnosed with; Genetic kidney diseases, Inflammatory or Infectious type nephropathy (Glomerulonephritis, SLE, M - Nephropathy / Pyelonephritis, PIGN, etc) Type 1 Diabetes Mellitus, Uncontrolled Diabetes and Hypertension, Morbid obesity, Acute Kidney Injury (AKI) Persons identified with renal carcinoma, polycystic kidney disease, UTI, Kidney stones Severe cognitive decline, immobilized or severe mobility restriction Persons identified with any other serious problem that can confound the outcome data

Design outcomes

Primary

MeasureTime frame
TGF beta1 Serum Creatinine Serum Cystatin C Urinary Albumin and Creatinine Oxidized Low-density Lipoprotein Malondialdehyde Advanced Oxidative Protein Products Superoxide Dismutase Glutathione peroxidase Catalase HRQoL measures Glomerular Filtration Rate Urinary Albumin Creatinine Ratio Timepoint: Before and after the intervention

Secondary

MeasureTime frame
Fasting Blood Sugar (FBS) Post Prandial Blood Sugar (PPBS) HbA1C: Glycated Haemoglobin Blood Pressure: (Systolic / Diastolic) Anthropometrics Timepoint: Before and after the intervention

Countries

India

Contacts

Public ContactRajesh G Nair

SVYASA university

ramesh.mavathur@gmail.com9611161845

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026